NervGen Pharma appoints new president & CEO
Source: SeekingAlpha
2026-02-09 08:05:05 ET
More on NervGen Pharma
- NervGen Pharma announces $10M non-brokered private placement
- Seeking Alpha’s Quant Rating on NervGen Pharma
- Historical earnings data for NervGen Pharma
- Financial information for NervGen Pharma
Read the full article on Seeking Alpha
For further details see:
NervGen Pharma appoints new president & CEO
Nervgen Pharma Corp.
NASDAQ: NGEN:CC
NGEN:CC Trading
-6.67% G/L:
$2.24 Last:
40,579 Volume:
$2.34 Open:
